KYMR
Kymera Therapeutics, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Kymera Therapeutics (KYMR) Stock: Buy, Sell, or Hold?
$128.64
-6.20 (-4.60%)
âŧ
5d:
+0.41%
30d:
+20.42%
90d:
+9.58%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Oct 29, 2026
0d
Protect KYMR Gains
Updated Nov 12, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (25%)
Quality Score
37/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$107.71 â $129.11
Position: SLIGHTLY HIGH
Forward P/E & Valuation
-26.4x
Next 12M consensus est.
Wall Street Target
$145.22
+7.7% upside
Options IV & Volume
72th pct IV
HIGH volume confirmation
Support / Resistance
$117.31 / $142.92
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: KYMR is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When KYMR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: KYMR is currently trading at $128.64, which is considered slightly high relative to its 30-day fair value range of $107.71 to $129.11.
Technical Outlook: Technically, KYMR is in a uptrend. Immediate support is located at $117.31, while resistance sits at $142.92. Short-term momentum is weak, with the stock down 4.6% recently.
Market Sentiment: KYMR scores 8/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Implied Volatility is high (72th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, KYMR is in a uptrend. Immediate support is located at $117.31, while resistance sits at $142.92. Short-term momentum is weak, with the stock down 4.6% recently.
Market Sentiment: KYMR scores 8/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Implied Volatility is high (72th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$107.71 -
$129.11
Company Quality Score
37/100
(SELL)
Options IV Signal
72th percentile
(EVENT RISK)
Volume Confirmation
HIGH
Confidence Score
25.0%
Trading Range & Key Levels
30-Day Trading Range
$107.71 -
$129.11
Current vs Trading Range
SLIGHTLY HIGH
Expected Move (7 Days)
Âą$23.79
(18.5%)
Support Level
$117.31
Resistance Level
$142.92
Current Trend
Uptrend
Technical data as of
Nov 12, 2026
Protect Your Profits
Holding KYMR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Options expensive (IV 72th percentile)
- BEARISH: Weak technical setup (8/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.6%)
- NEUTRAL: Near Wall St target ($145.22)
- WARNING: Composite score 37/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-26.35
Wall Street Target
$145.22
(+7.7%)
Revenue Growth (YoY)
466.4%
Share KYMR Analysis
Share this live KYMR analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (KYMR)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 28, 2026
Daily AI digest
AI Retail Discussion Summary:
Investors are bullish on $KYMR ahead of earnings, with focus on the potential of lead immunology candidate KT-621. Kymera Therapeutics is priced below analyst target and trades on a significant cash runway, implying potential for long-term earnings growth.
Key Retail Themes:
Upcoming earnings report
Potential of KT-621
Valuation and fair value estimates
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 1:32 PM ET
Data refreshes hourly during market hours. Next update: 2:32 PM
Data refreshes hourly during market hours. Next update: 2:32 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KYMR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals âĻ |
STRONG BUY
30 analysts |
$302 | 51 HOLD |
|
VRTX
Vertex Pharmaceuticals IâĻ |
STRONG BUY
32 analysts |
$592 | 39 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
21 analysts |
$304 | 36 SELL |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
15 analysts |
$22 | 67 BUY |
|
IDYA
Ideaya Biosciences Inc |
STRONG BUY
16 analysts |
$51 | 60 BUY |
Advanced KYMR Option Strategies
Professional options setups generated by AI based on today's KYMR price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive KYMR Research Pages
